Table 4.
Study | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 | Q12 | Q13 | % yes | Riskb |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cohort studies | |||||||||||||||
Warr et al. (71) | ✓ | ✓ | ✓ | × | × | ✓ | × | ✓ | × | × | ✓ | N/A | N/A | 55% (6/11) | Moderate |
Watson-Jones et al. (75) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | × | × | ✓ | N/A | N/A | 82% (9/11) | Low |
Afolabi et al. (77) | ✓ | ✓ | ✓ | × | ✓ | ✓ | ? | ✓ | × | × | ✓ | N/A | N/A | 68% 7.5/11 | Moderate |
Govender et al. (74) | ✓ | ✓ | ✓ | × | × | ✓ | ? | ✓ | × | × | ✓ | N/A | N/A | 59% 6.5/11 | Moderate |
Slyker et al. (79) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | × | ✓ | × | × | ✓ | N/A | N/A | 73% 8/11 | Low |
Donders et al. (84) | × | ✓ | × | × | × | N/A | ? | × | × | ✓ | N/A | N/A | 25% 2.5/10 | High | |
Cross sectional studies | |||||||||||||||
Aduloju et al. (72) | ✓ | ✓ | ✓ | ✓ | × | ? | ✓ | N/A | N/A | N/A | N/A | N/A | 69% (5.5/8) | Moderate | |
Shayo et al. (73) | ✓ | ✓ | ✓ | ✓ | × | × | ? | ✓ | N/A | N/A | N/A | N/A | N/A | 69% (5.5/8) | Moderate |
Case-control studies | |||||||||||||||
Aderoba et al. (80) | × | × | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | N/A | N/A | N/A | 80% (8/10) | Low |
Nakubulwa et al. (70) | ✓ | ✓ | ✓ | × | × | × | ✓ | ✓ | N/A | N/A | N/A | 50% (5/10) | Moderate | ||
Randomized controlled trial | |||||||||||||||
Schoeman et al. (78) | ✓ | ✓ | ✓ | ✓ | ✓ | ? | ✓ | ✓ | ? | ✓ | ? | ✓ | ✓ | 84% 11/13 | Low |
Odendaal et al. (76) | ✓ | ✓ | ✓ | ? | ? | ? | ✓ | × | ? | ✓ | ✓ | ✓ | ✓ | 77% 10/13 | Low |
Studies included in this review were assessed for risk of bias according to JBI (Joanna Briggs Institute) Critical Appraisal Tool, detailed in reference (66) and Supplementary Material 2. ✓, Indicates yes (1 point); ×, Indicates No (0 points); “?”, Indicates unclear (0.5 points). Riskb: The risk of bias was ranked as high when the study score reached up to 49%, moderate when the study score reached from 50 to 69%, and low when the study score reached more than 70%. N/A, not applicable.